Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite-Reference-Cited by-同舟云学术

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Published:2021-05 Issue:5 Volume:29 Page:819-833.e7
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Cerutti Gabriele,Guo Yicheng,Zhou Tongqing,Gorman Jason,Lee Myungjin,Rapp Micah,Reddem Eswar R.,Yu Jian,Bahna Fabiana,Bimela Jude,Huang Yaoxing,Katsamba Phinikoula S.,Liu Lihong,Nair Manoj S.,Rawi Reda,Olia Adam S.,Wang Pengfei,Zhang Baoshan,Chuang Gwo-Yu,Ho David D.,Sheng Zizhang,Kwong Peter D.,Shapiro Lawrence

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference80 articles.

1. Recent developments in the PHENIX software for automated crystallographic structure determination;Adams;J. Synchrotron Radiat.,2004

2. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

3. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy;Barad;Nat. Methods,2015

4. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

5. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies;Barnes;Cell,2020

Cited by 470 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics;International Journal of Biological Macromolecules;2024-10

2. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

3. Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants;Nature Communications;2024-08-31

4. Glycan masking of NTD loops with a chimeric RBD of the spike protein as a vaccine design strategy against emerging SARS‐CoV‐2 Omicron variants;Journal of Medical Virology;2024-08-28

5. Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting;2024-08-15